97 related articles for article (PubMed ID: 15515016)
21. Two Epstein-Barr virus-related serologic antibody tests in nasopharyngeal carcinoma screening: results from the initial phase of a cluster randomized controlled trial in Southern China.
Liu Z; Ji MF; Huang QH; Fang F; Liu Q; Jia WH; Guo X; Xie SH; Chen F; Liu Y; Mo HY; Liu WL; Yu YL; Cheng WM; Yang YY; Wu BH; Wei KR; Ling W; Lin X; Lin EH; Ye W; Hong MH; Zeng YX; Cao SM
Am J Epidemiol; 2013 Feb; 177(3):242-50. PubMed ID: 23255783
[TBL] [Abstract][Full Text] [Related]
22. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM
J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
Liu MT; Yeh CY
Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
[TBL] [Abstract][Full Text] [Related]
24. Combined determination of Epstein-Barr virus-related antibodies and antigens for diagnosis of nasopharyngeal carcinoma.
Luo YL; Ou GP; Chi PD; Liang YN; Liu YH; Huang MY
Ai Zheng; 2009 Jan; 28(1):76-8. PubMed ID: 19448423
[TBL] [Abstract][Full Text] [Related]
25. [Clinical analysis and long-term follow up study of asymptomatic nasopharyngeal carcinoma patients].
Ji MF; Guo YQ; Zheng SA; Liang JS; Wang DK; Ou XT
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 38(1):53-6. PubMed ID: 12778770
[TBL] [Abstract][Full Text] [Related]
26. [Significance of cell-free Epstein-Barr virus DNA in monitoring prognosis of nasopharyngeal carcinoma].
Cao SM; Min HQ; Gao JS; Hong MH; Xiao XB; Zhang CQ; Liu XD; Zhang AL; Guo X
Ai Zheng; 2003 Mar; 22(3):302-6. PubMed ID: 12654192
[TBL] [Abstract][Full Text] [Related]
27. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
28. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men.
Chien YC; Chen JY; Liu MY; Yang HI; Hsu MM; Chen CJ; Yang CS
N Engl J Med; 2001 Dec; 345(26):1877-82. PubMed ID: 11756578
[TBL] [Abstract][Full Text] [Related]
29. Serological diagnosis of nasopharyngeal carcinoma by enzyme linked immunosorbent assay: optimization, standardization and diagnostic criteria.
Ng MH; Chen HL; Luo RX; Chan KH; Woo PC; Sham JS; Huang J; Seto WH; Smith P; Griffin BE
Chin Med J (Engl); 1998 Jun; 111(6):531-6. PubMed ID: 11245074
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Haryana SM; Middeldorp JM
J Clin Virol; 2008 Aug; 42(4):343-52. PubMed ID: 18455473
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus seroepidemiology in China.
Zeng Y; Pi GH; Deng H; Zhang JM; Wang PC; Wolf H; De Thé G
AIDS Res; 1986 Dec; 2 Suppl 1():S7-15. PubMed ID: 3030349
[TBL] [Abstract][Full Text] [Related]
32. Salivary Epstein-Barr virus DNA level in patients with nasopharyngeal carcinoma following radiotherapy.
Pow EH; Law MY; Tsang PC; Perera RA; Kwong DL
Oral Oncol; 2011 Sep; 47(9):879-82. PubMed ID: 21767975
[TBL] [Abstract][Full Text] [Related]
33. Use of recombinant Epstein-Barr virus early antigen for detection of antibody in patients with nasopharyngeal carcinoma.
Liu MT; Lin LS; Yu Y; Chung TT; Hsu CY; Chen JT; Jeng KC
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):7-15. PubMed ID: 8820030
[TBL] [Abstract][Full Text] [Related]
34. Detection of IgA against Epstein-Barr virus BZLF-1 replication activator (ZEBRA) in sera of nasopharyngeal carcinoma patients with a recombinant ZEBRA protein.
Shu CH; Tu TY; Lin LS; Ro LH; Lo MS; Huang CH; Chen KY; Liu WT
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):350-5. PubMed ID: 10389292
[TBL] [Abstract][Full Text] [Related]
35. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M
J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
[TBL] [Abstract][Full Text] [Related]
36. Familial nasopharyngeal carcinoma in Hong Kong: epidemiology and implication in screening.
Ng WT; Choi CW; Lee MC; Chan SH; Yau TK; Lee AW
Fam Cancer; 2009; 8(2):103-8. PubMed ID: 18726711
[TBL] [Abstract][Full Text] [Related]
37. Incidence and Demographics of Nasopharyngeal Carcinoma in Cheung Chau Island of Hong Kong-A Distinct Geographical Area With Minimal Residential Mobility and Restricted Public Healthcare Referral Network.
Chan SK; Chau SC; Chan SY; Tong CC; Lam KO; Lai-Wan Kwong D; Leung TW; Luk MY; Lee AW; Choi HC; Lee VH
Cancer Control; 2021; 28():10732748211047117. PubMed ID: 34565216
[TBL] [Abstract][Full Text] [Related]
38. Tobacco smoking, family history, and the risk of nasopharyngeal carcinoma: a case-referent study in Hong Kong Chinese.
Xie SH; Yu IT; Tse LA; Au JS; Lau JS
Cancer Causes Control; 2015 Jun; 26(6):913-21. PubMed ID: 25822573
[TBL] [Abstract][Full Text] [Related]
39. Sex difference in the incidence of nasopharyngeal carcinoma in Hong Kong 1983-2008: suggestion of a potential protective role of oestrogen.
Xie SH; Yu IT; Tse LA; Mang OW; Yue L
Eur J Cancer; 2013 Jan; 49(1):150-5. PubMed ID: 22892061
[TBL] [Abstract][Full Text] [Related]
40. Nasopharyngeal carcinoma: modes of presentation.
Skinner DW; Van Hasselt CA; Tsao SY
Ann Otol Rhinol Laryngol; 1991 Jul; 100(7):544-51. PubMed ID: 2064265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
